窝窝午夜理论片影院

【中国证券报-中证网】国药集团:首次迈进《财富》世界500强企业百强榜单
发布时(shi)间:2022-08-16

记者从国药集(ji)团(tuan)(tuan)8月(yue)15日举(ju)办的(de)媒体通气会(hui)上(shang)获悉,在8月(yue)3日发布的(de)《财富(fu)》世界(jie)500强企业榜(bang)单中(zhong),国药集(ji)团(tuan)(tuan)位(wei)列(lie)第80位(wei),首次迈(mai)进百强榜(bang)单。

“从2013年(nian)首次入(ru)围《财富》杂志世界500强(qiang)排行(xing)榜,到(dao)2022年(nian)挺(ting)进(jin)百强(qiang),国(guo)药(yao)集团排名连续十年(nian)上升。”国(guo)药(yao)集团副总经理胡(hu)建伟表示,国(guo)药(yao)集团在这十年(nian)里深化国(guo)企改革(ge),战略性重(zhong)组和(he)专业化整合取得积极进(jin)展。十年(nian)来,国(guo)药(yao)集团营业收入(ru)从2046亿(yi)元(yuan)增(zeng)至7017亿(yi)元(yuan),资(zi)(zi)产(chan)总额从1683亿(yi)元(yuan)增(zeng)长到(dao)5640亿(yi)元(yuan)。2021年(nian),国(guo)药(yao)集团利(li)润总额突破(po)千亿(yi),净资(zi)(zi)产(chan)收益率和(he)国(guo)有资(zi)(zi)产(chan)保(bao)值增(zeng)值率位列中央(yang)企业第一(yi)位,连续9个年(nian)度和(he)3个任(ren)期获评中央(yang)企业经营业绩考核A级(ji)。

国(guo)(guo)药(yao)集团在中(zhong)药(yao)板块方面表现亮眼。国(guo)(guo)药(yao)中(zhong)药(yao)总经理、中(zhong)药(yao)控股董事长(zhang)陈映龙(long)介绍,目前国(guo)(guo)药(yao)集团中(zhong)药(yao)板块中(zhong)药(yao)配方颗粒科研技术生(sheng)产能(neng)(neng)(neng)力、市场规模居于(yu)全(quan)国(guo)(guo)第(di)一(yi)(yi),中(zhong)药(yao)材基地布局和(he)产地初加(jia)工(gong)能(neng)(neng)(neng)力位列全(quan)国(guo)(guo)第(di)一(yi)(yi),中(zhong)药(yao)饮片共享中(zhong)药(yao)智能(neng)(neng)(neng)配送中(zhong)心模式为全(quan)国(guo)(guo)第(di)一(yi)(yi),中(zhong)成药(yao)品种数量和(he)生(sheng)产能(neng)(neng)(neng)力位居全(quan)国(guo)(guo)第(di)一(yi)(yi),生(sheng)产质量、控制标准(zhun)和(he)可追溯质量保障(zhang)体系全(quan)国(guo)(guo)领先。

2012年至2021年,国药(yao)集团现(xian)代中药(yao)板(ban)块经营效(xiao)益大幅提升。截(jie)至2021年底,国药(yao)集团现(xian)代中药(yao)板(ban)块资产规模达到546.05亿(yi)(yi)元,实现(xian)营业收(shou)入327.55亿(yi)(yi)元,净利(li)润20.69亿(yi)(yi)元。

与(yu)此同时,国(guo)药(yao)(yao)(yao)(yao)(yao)(yao)集(ji)团(tuan)(tuan)坚(jian)持拓(tuo)展(zhan)中(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)(yao)产(chan)业(ye)(ye)链覆(fu)盖的(de)广度与(yu)深度,强(qiang)化完善药(yao)(yao)(yao)(yao)(yao)(yao)品全生(sheng)命周期管理(li)。一(yi)方(fang)面(mian),提升中(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)(yao)材(cai)生(sheng)产(chan)水平。深入道(dao)地产(chan)区,强(qiang)化种(zhong)(zhong)子(zi)种(zhong)(zhong)苗良种(zhong)(zhong)繁(fan)育研究(jiu),为产(chan)业(ye)(ye)链下(xia)(xia)游提供有质量保障(zhang)的(de)药(yao)(yao)(yao)(yao)(yao)(yao)材(cai)种(zhong)(zhong)子(zi),并强(qiang)化规(gui)(gui)范化生(sheng)产(chan)与(yu)经营。国(guo)药(yao)(yao)(yao)(yao)(yao)(yao)集(ji)团(tuan)(tuan)现代(dai)中(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)(yao)板(ban)块(kuai)(kuai)自2019年起累计建设中(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)(yao)材(cai)GACP基地200多个,覆(fu)盖80多个品种(zhong)(zhong),种(zhong)(zhong)植面(mian)积逾30万亩。另一(yi)方(fang)面(mian),加(jia)快中(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)(yao)工业(ye)(ye)转(zhuan)型升级。国(guo)药(yao)(yao)(yao)(yao)(yao)(yao)集(ji)团(tuan)(tuan)旗下(xia)(xia)的(de)一(yi)方(fang)制药(yao)(yao)(yao)(yao)(yao)(yao)、天(tian)江药(yao)(yao)(yao)(yao)(yao)(yao)业(ye)(ye)占国(guo)内中(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)(yao)配方(fang)颗粒超过(guo)(guo)52%的(de)市场份额。中(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)(yao)饮片板(ban)块(kuai)(kuai)业(ye)(ye)务(wu)覆(fu)盖全国(guo)重点(dian)城市。中(zhong)(zhong)(zhong)(zhong)成药(yao)(yao)(yao)(yao)(yao)(yao)板(ban)块(kuai)(kuai)整合了中(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)(yao)控股和国(guo)药(yao)(yao)(yao)(yao)(yao)(yao)太(tai)极两(liang)大产(chan)品线,拥(yong)有包括藿香(xiang)正(zheng)气液、急支糖浆、玉屏风化湿败毒颗粒等超过(guo)(guo)1500个成药(yao)(yao)(yao)(yao)(yao)(yao)品规(gui)(gui)。国(guo)药(yao)(yao)(yao)(yao)(yao)(yao)集(ji)团(tuan)(tuan)还积极发展(zhan)中(zhong)(zhong)(zhong)(zhong)医药(yao)(yao)(yao)(yao)(yao)(yao)健(jian)康服务(wu)业(ye)(ye),在多个省市落地国(guo)医馆(guan),提供多元化中(zhong)(zhong)(zhong)(zhong)医药(yao)(yao)(yao)(yao)(yao)(yao)健(jian)康服务(wu)。

版权所有:国药集团
【中国证券报-中证网】国药集团:首次迈进《财富》世界500强企业百强榜单
发布时间:2022-08-16

记(ji)者从国(guo)药集团(tuan)8月15日(ri)举办的媒体通(tong)气会(hui)上获悉,在8月3日(ri)发布的《财富》世(shi)界500强企业榜(bang)单中(zhong),国(guo)药集团(tuan)位列第80位,首次(ci)迈进(jin)百强榜(bang)单。

“从2013年(nian)(nian)首次入(ru)围《财富》杂志(zhi)世界500强排行榜,到(dao)2022年(nian)(nian)挺进(jin)百强,国(guo)(guo)药集团(tuan)(tuan)排名连续(xu)十年(nian)(nian)上(shang)升。”国(guo)(guo)药集团(tuan)(tuan)副总(zong)经理胡(hu)建伟表示(shi),国(guo)(guo)药集团(tuan)(tuan)在(zai)这十年(nian)(nian)里深(shen)化国(guo)(guo)企改革,战略性重组和(he)专业(ye)化整合取(qu)得积极进(jin)展(zhan)。十年(nian)(nian)来,国(guo)(guo)药集团(tuan)(tuan)营业(ye)收入(ru)从2046亿元(yuan)增(zeng)至7017亿元(yuan),资产总(zong)额从1683亿元(yuan)增(zeng)长到(dao)5640亿元(yuan)。2021年(nian)(nian),国(guo)(guo)药集团(tuan)(tuan)利润总(zong)额突破千亿,净资产收益率和(he)国(guo)(guo)有资产保(bao)值增(zeng)值率位列中央企业(ye)第一位,连续(xu)9个(ge)年(nian)(nian)度和(he)3个(ge)任期(qi)获评中央企业(ye)经营业(ye)绩考核A级。

国(guo)药(yao)(yao)(yao)集团在中(zhong)药(yao)(yao)(yao)板块方面(mian)表现(xian)亮眼。国(guo)药(yao)(yao)(yao)中(zhong)药(yao)(yao)(yao)总经(jing)理、中(zhong)药(yao)(yao)(yao)控(kong)股(gu)董事长陈映(ying)龙介绍(shao),目前(qian)国(guo)药(yao)(yao)(yao)集团中(zhong)药(yao)(yao)(yao)板块中(zhong)药(yao)(yao)(yao)配方颗粒科(ke)研技术生产能(neng)力(li)(li)、市场规模居(ju)于全(quan)(quan)(quan)国(guo)第(di)一(yi),中(zhong)药(yao)(yao)(yao)材(cai)基(ji)地(di)布(bu)局和产地(di)初加工能(neng)力(li)(li)位列全(quan)(quan)(quan)国(guo)第(di)一(yi),中(zhong)药(yao)(yao)(yao)饮片共享中(zhong)药(yao)(yao)(yao)智能(neng)配送中(zhong)心模式为全(quan)(quan)(quan)国(guo)第(di)一(yi),中(zhong)成药(yao)(yao)(yao)品种(zhong)数量(liang)和生产能(neng)力(li)(li)位居(ju)全(quan)(quan)(quan)国(guo)第(di)一(yi),生产质量(liang)、控(kong)制标准和可追溯质量(liang)保障体系全(quan)(quan)(quan)国(guo)领先(xian)。

2012年(nian)至(zhi)(zhi)2021年(nian),国药(yao)集团现(xian)(xian)代中(zhong)药(yao)板块经营效益大幅提(ti)升。截至(zhi)(zhi)2021年(nian)底,国药(yao)集团现(xian)(xian)代中(zhong)药(yao)板块资产规模达到546.05亿(yi)元,实现(xian)(xian)营业收入327.55亿(yi)元,净(jing)利(li)润20.69亿(yi)元。

与(yu)此同时,国(guo)(guo)药(yao)(yao)集团坚持拓展中(zhong)药(yao)(yao)产(chan)业(ye)(ye)链(lian)覆(fu)盖的(de)广度与(yu)深度,强化(hua)完善药(yao)(yao)品(pin)(pin)全(quan)生命周期管理。一(yi)方(fang)面(mian)(mian),提(ti)升(sheng)中(zhong)药(yao)(yao)材(cai)(cai)生产(chan)水平(ping)。深入(ru)道(dao)地(di)产(chan)区(qu),强化(hua)种(zhong)(zhong)(zhong)子(zi)种(zhong)(zhong)(zhong)苗良种(zhong)(zhong)(zhong)繁育研究,为产(chan)业(ye)(ye)链(lian)下游提(ti)供(gong)有(you)质量(liang)保障的(de)药(yao)(yao)材(cai)(cai)种(zhong)(zhong)(zhong)子(zi),并强化(hua)规(gui)范化(hua)生产(chan)与(yu)经营。国(guo)(guo)药(yao)(yao)集团现代(dai)中(zhong)药(yao)(yao)板块(kuai)(kuai)自2019年起累(lei)计(ji)建(jian)设中(zhong)药(yao)(yao)材(cai)(cai)GACP基地(di)200多个(ge),覆(fu)盖80多个(ge)品(pin)(pin)种(zhong)(zhong)(zhong),种(zhong)(zhong)(zhong)植面(mian)(mian)积逾30万亩。另一(yi)方(fang)面(mian)(mian),加快中(zhong)药(yao)(yao)工(gong)业(ye)(ye)转型(xing)升(sheng)级。国(guo)(guo)药(yao)(yao)集团旗下的(de)一(yi)方(fang)制药(yao)(yao)、天江药(yao)(yao)业(ye)(ye)占国(guo)(guo)内(nei)中(zhong)药(yao)(yao)配方(fang)颗(ke)粒超过52%的(de)市场份(fen)额。中(zhong)药(yao)(yao)饮片板块(kuai)(kuai)业(ye)(ye)务(wu)覆(fu)盖全(quan)国(guo)(guo)重点城市。中(zhong)成药(yao)(yao)板块(kuai)(kuai)整合了(le)中(zhong)药(yao)(yao)控股和国(guo)(guo)药(yao)(yao)太极两大(da)产(chan)品(pin)(pin)线,拥有(you)包括藿香(xiang)正气液、急(ji)支糖浆(jiang)、玉屏(ping)风化(hua)湿败(bai)毒颗(ke)粒等超过1500个(ge)成药(yao)(yao)品(pin)(pin)规(gui)。国(guo)(guo)药(yao)(yao)集团还积极发展中(zhong)医药(yao)(yao)健康服务(wu)业(ye)(ye),在多个(ge)省市落地(di)国(guo)(guo)医馆(guan),提(ti)供(gong)多元化(hua)中(zhong)医药(yao)(yao)健康服务(wu)。

版权所有:国药集团